-- ウェスファーマーズ(ASX:WES)は、ビルト・グループと50:50の合弁事業を設立することで合意した。この合弁事業は、先進的な製造技術を用いて大規模な集合住宅供給を行うオーストラリアの新会社、ビルト・リビングの設立を目的としたもの。ウェスファーマーズは当初、最大1億豪ドルの出資を行う予定である。これは火曜日にオーストラリア証券取引所に提出された書類で明らかになった。 同社によると、ビルト・リビングは設計・製造・組立(DfMA)方式を採用し、従来工法に比べて約20%のコスト削減と50%の工期短縮を目指す。西オーストラリア州に設立される施設は、完成後、年間2,000戸以上の集合住宅供給を支える見込みだ。 提出書類によると、施設の建設は下半期に開始される予定で、西オーストラリア州政府はニーラブアップ・オートメーション・アンド・ロボティクス地区の土地の長期リースと施設開発への直接支援を通じて、設立を支援する。 同社は、施設の年間生産能力の一部は政府支援の住宅プロジェクトや州の社会インフラ整備計画に充てられる予定であり、Built Livingの設立は、Bunningsのトレード事業との供給契約などを通じて、Wesfarmersの既存事業にも成長機会をもたらすと期待していると述べた。 Built Livingは、Wesfarmersが当初の1億豪ドルの投資を全額実行した後、WesfarmersとBuiltが同数の取締役で構成される独立企業として運営される予定であると、同社は述べた。 同社はまた、この投資が当会計年度の収益に大きな影響を与えるとは予想していないと付け加えた。
Related Articles
Star Sports Medicine Soars 192% in Hong Kong Trading Debut
Star Sports Medicine's (HKG:1609) shares opened 192.4% above their initial public offering price in a stellar Hong Kong debut Tuesday morning.The China-based medical device company opened at HK$288 per share, well above the offer price of HK$98.50.
Impact Therapeutics Launches Up to HK$913 Million Hong Kong IPO
Impact Therapeutics (HKG:7630) launched its Hong Kong initial public offering on Tuesday, seeking to raise up to about HK$913 million from the deal.The China-based biotechnology company is offering 42 million shares at an indicative maximum price of HK$21.75 per share, according to a Hong Kong bourse filing.The offering comprises 4.2 million shares for Hong Kong investors and 37.8 million shares for international investors, subject to reallocation and the overallotment option.The offer price is expected to be determined by May 11, with allocation results due by May 12, ahead of the company's planned trading debut on May 13.Net proceeds will be used mainly to fund the clinical development, regulatory approval, and commercialization of its core product, senaparib, as well as support the development of key pipeline products.The funds will also be used for research and development of other pipeline assets, expansion of R&D platforms, and for working capital and general corporate purposes.Goldman Sachs (Asia) and China International Capital Corporation Hong Kong Securities are acting as joint sponsors.Goldman Sachs (Asia) and China International Capital Corporation Hong Kong Securities are serving as overall coordinators and are also acting as joint bookrunners and joint lead managers.CMB International Capital is acting as a joint global coordinator and joint lead manager, while Tiger Brokers (HK) Global is acting as a joint bookrunner and joint lead manager.
Market Chatter: SK Hynix Shares Gain 13% After US Tech Giants Signal No Slowdown in AI Spending
Shares of SK Hynix (KRX:000660) closed nearly 13% higher on Monday, ending trading at a new high of 1,447,000 won per share, after all four of the US tech giants indicated that spending on AI will not slow down, Reuters said in a same-day report.Total AI spending is estimated to surpass $700 billion in 2026, up from about $600 billion previously, as Microsoft and Meta announced larger-than-expected capital expenditure plans, which were partly led by higher memory chip prices, while maintaining confidence in their investments, the report said.In addition, Bank of Korea Senior Deputy Governor Ryoo Sang-dai said that the current chip market boom is likely to last longer as compared to past cycles, echoing similar outlooks from Samsung Electronics (KRX:005930) and SK Hynix during their earnings calls in April, it said.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)